eMedEd

eMedEd, Inc.

Access expert Oncology insights on liquid biopsies, rare cancer therapies, epigenetics, survivorship, and targeted treatments that are reshaping cancer care and long-term outcomes.

Oncology – Clinical Insights &amp; Resources | eMedEd

Oncology Articles

Liquid biopsies offer a non-invasive, real-time method for early cancer detection, personalized treatment planning, and monitoring. They are revolutionizing oncology care and improving patient outcomes with cutting-edge biomarker analysis.

The Role of Liquid Biopsies in Early Cancer Detection

Emerging therapies like precision medicine, immunotherapy, and gene editing are revolutionizing rare cancer treatment, bridging gaps in diagnosis, and offering new hope for patients worldwide.

Emerging Therapies for Rare Cancers: Bridging the Treatment Gap

Epigenetics revolutionizes cancer care by targeting reversible gene changes, enabling personalized treatment, early detection, and prevention strategies for improved patient outcomes.

The Role of Epigenetics in Cancer Treatment and Prevention

Discover how epigenetics is revolutionizing cancer treatment. Learn about DNA methylation, histone modifications, and the latest epigenetic therapies transforming oncology.

Epigenetics and Cancer: Unlocking New Treatment Avenues

Learn about the challenges of cancer survivorship and the importance of long-term care. Discover how survivors can thrive after treatment with comprehensive support.

Cancer Survivorship and Long-Term Care: Navigating Life After Treatment

Discover how targeted therapies are revolutionizing the treatment of rare cancers. Learn about genomic profiling, breakthrough drugs, and the future of precision medicine.

Targeted Therapies for Rare Cancers: A New Hope for Patients

CAR-T therapy is rapidly evolving beyond blood cancers. Advances in engineering and combination strategies are unlocking new possibilities for treating solid tumors once considered resistant to immunotherapy.

CAR-T Therapy for Solid Tumors: Emerging Advances, Barriers, and Future Directions

Immunotherapy resistance is a growing challenge in oncology. Understanding the mechanisms, biomarkers, and therapeutic strategies is essential for physicians seeking to improve outcomes and overcome treatment failure.

Immunotherapy Resistance in Cancer: Mechanisms, Biomarkers, and Strategies to Overcome It

Home

Resources

Oncology

Learn how liquid biopsies provide a non-invasive, real-time method for early cancer detection, biomarker analysis, and personalized treatment planning.

Explore how precision medicine, immunotherapy, and gene-editing approaches are transforming treatment options and outcomes for patients with rare cancers.

Understand how epigenetic mechanisms such as DNA methylation and histone modification enable targeted cancer therapies, prevention strategies, and personalized care.

Discover how epigenetic targets and novel agents are opening new pathways for cancer treatment and resistance management.

Review the challenges of survivorship, late effects of therapy, and strategies for long-term, holistic follow-up care in oncology patients.

Learn how targeted agents and molecularly guided therapies are reshaping the outlook for patients with rare and difficult-to-treat cancers.